Crossmark

Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence

Crossref DOI link: https://doi.org/10.1007/s40261-019-00793-6

Published Online: 2019-05-03

Published Print: 2019-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yeganeh Salehpour, Mahshid

Mollica, Adriano

Momtaz, Saeideh

Sanadgol, Nima

Farzaei, Mohammad Hosein https://orcid.org/0000-0001-7081-6521
License Information

Text and Data Mining valid from 2019-05-03
More Information

Article History

First Online: 3 May 2019

Compliance with Ethical Standards

:

: No source funding was used to prepare this review.

: The authors declare that they have no conflicts of interest.